7.33 USD
↘ 0.04 (0.48%)PRE MARKET (AS OF 07:20 AM EDT)
Cartesian Therapeutics, Inc. Common Stock
RNACNASDAQ • USD
Market: OPEN
Cartesian Therapeutics, Inc. Common Stock (RNAC) trades at $7.33 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (122.9%) and a bullish Golden Cross on the moving averages. On the valuation front, RNAC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 2, 2026.
Open?$7.62
High?$7.62
Low?$7.33
Prev. Close?$7.36
Volume?N/A
Avg. Volume?124.5K
Bid / Ask
Bid?$6.36 × 100
Ask?$9.10 × 100
Spread?$2.74
Midpoint?$7.73
Valuation & Ratios
Market Cap?222.7M
Shares Out?30.3M
Float?12.1M
Float %?41.0%
P/E Ratio?N/A
P/B Ratio?-1.78
EPS?-$5.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Themes
Employees
75
Market Cap
222.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-22
Address
7495 NEW HORIZON WAY
FREDERICK, MD 21703
Phone: 301-348-8698
FREDERICK, MD 21703
Phone: 301-348-8698
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?35
Short Sent.?28
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.52Distress
Confidence?60%Moderate
Short InterestVery High
Short % of Float?14.95%High
Short Interest?1.8M
Days to Cover?17.0
Free Float12.1M
Avg Daily Volume106.1K
Settlement Date2026-09-15
Financial Health
Current Ratio?7.48Strong
Quick Ratio?7.48Strong
Cash Ratio?7.18Strong
Debt/Equity?-0.42Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-1.78CHEAP▾
S&P97
P/S?150.76HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.3CHEAP▾
S&P97
EV/Sales?86.61HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?122.9%STRONG▾
Peers50
S&P97
ROA?-48.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-78612000
Enterprise Value?$127.9M
Fundamentals ratios updated end of day